Peptides News

HRV Pharma is investing ₹150 crore in peptides and high-potency oncology APIs, marking a strategic shift in its business model. This investment moves the compan

Doctors are raising concerns about the growing trend of using injectable peptides for various health benefits, distinguishing them from established peptide medi

A new study has found that peptides can remain stable in concentrated sulphuric acid, a discovery that has implications for the search for life beyond Earth. Th

A new trend involves injecting banned peptides to 'optimize' the body, with unauthorized synthetic peptides promoted by influencers and gyms despite being diffe

Researchers are raising concerns about the unregulated use of experimental peptides, driven by social media hype and distrust of public health guidance, leading

The owner of an online peptide company has been sentenced to nearly six years in prison after a federal judge found the business deceived customers and sold pro

The article discusses how compounding pharmacies, now under the influence of figures like Robert F Kennedy Jr., are contributing to a "wild west" of untested dr

An FDA panel has cleared the way for six previously banned peptides to be produced by compounding pharmacies.

An F.D.A. panel's vote on peptides has raised concerns about a potential prescribing boom. The committee endorsed broader use of peptides in lightly regulated c

A committee hand-picked by RFK Jr. and organized by the FDA has voted to approve removing restrictions on the manufacture of certain peptides for human use, des

An FDA panel has endorsed adding several unproven peptides, including the "Wolverine stack" promoted by Joe Rogan, to the agency's bulks list. This recommendati

An FDA committee voted against the agency's staff advice to recommend adding two peptides, BP-157 and KPV, to a list allowing specialty pharmacies to dispense t

The FDA is currently evaluating whether compounding pharmacies should be permitted to produce BPC-157, TB-500, and other peptides that were previously banned.

The Biden administration is reviewing certain peptides, including BPC-157, TB-500, and Semax, and has restricted their compounding due to a lack of human clinic

Health experts are cautioning against unapproved peptides as the FDA convenes an advisory committee to discuss easing restrictions on compounding pharmacies dis

US regulators are set to evaluate controversial peptides, which have seen surging demand and are promoted for benefits like improved sleep, muscle growth, and a

A U.S. FDA panel will review whether seven popular peptides can be compounded by licensed pharmacies, though industry experts expect strong consumer demand to p

With an FDA panel expected to recommend the legal production of several peptides this week, compounding pharmacies and telehealth companies are preparing for a

The FDA's compounding advisory committee is set to review seven peptides on July 23 and 24 for potential approval, which could open up a multibillion-dollar mar